The proportion of patients achieving LDL-C target as defined by Swiss cholesterol recommendations (AGLA-recommendations) across starting doses of 10 mg, 20 mg, 40 mg, and 80 mg of atorvastatin.

Inclusion Criteria:

• Risk factors and diagnosis of dyslipidemia according to the AGLA-recommendations (see appendix B) at screening
• LDL-C < 6.0 mmol/l
• Triglyceride level < 5.0 mmol/l.

Exclusion Criteria:

• Subjects receiving higher than "usual maintenance" doses of Lipid Lowering Therapy (LLT) at screening.